| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/28/2010 | US20100022454 Peptides with High Affinity for the Prolactin Receptor |
| 01/28/2010 | US20100022453 NoGo Receptor 1 and Fibroblast Growth Factor Interactions |
| 01/28/2010 | US20100022452 Nanobodies for the treatment of aggregation-mediated disorders |
| 01/28/2010 | US20100022451 Use of infant formula with reduced protein content |
| 01/28/2010 | US20100022450 Octreotide implant having a release agent |
| 01/28/2010 | US20100022449 Receptor-avid exogenous optical contrast and therapeutic agents |
| 01/28/2010 | US20100022448 Peptides |
| 01/28/2010 | US20100022447 Composition for treating cancer and use thereof |
| 01/28/2010 | US20100022446 Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity |
| 01/28/2010 | US20100022445 Biologically active peptides |
| 01/28/2010 | US20100022444 Combination therapy for modulation of activity and development of cells and tissues |
| 01/28/2010 | US20100022443 Derivatisation of erythropoietin (epo) |
| 01/28/2010 | US20100022442 Compositions and methods for increasing serum antioxidant concentrations, decreasing serum triglyceride levels, inhibiting insulin-receptor signaling activity, increasing serum ghrelin levels, and decreasing serum tnf-alpha levels |
| 01/28/2010 | US20100022441 N-terminal polysialylation |
| 01/28/2010 | US20100022440 VH4 Codon Signature For Multiple Sclerosis |
| 01/28/2010 | US20100022439 Nanostructures with High Load of Active Agents |
| 01/28/2010 | US20100022438 Method of separating carbon nanotubes |
| 01/28/2010 | US20100022401 Avidin-like proteins from symbiotic bacteria |
| 01/28/2010 | US20100022016 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 01/28/2010 | US20100021995 Biological products |
| 01/28/2010 | US20100021991 Methods for Producing Modified Glycoproteins |
| 01/28/2010 | US20100021951 Human Brain Carboxypeptidase B |
| 01/28/2010 | US20100021612 Method for the production of fusion proteins in transgenic mammal milk |
| 01/28/2010 | US20100021553 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 01/28/2010 | US20100021549 Microparticle oral form useful for the modified release of nanoparticles |
| 01/28/2010 | US20100021545 Injectable in situ self-forming mineral-polymer hybrid composition and uses thereof |
| 01/28/2010 | US20100021537 Comprising at least one digestive enzyme (e.g., pancrelipase); useful for treating or preventing disorders associated with digestive enzyme deficiencies; enteric coated enzyme compositions and dosage forms that exhibit minimal loss of activity under typical storage conditions |
| 01/28/2010 | US20100021536 Enhanced-diffusion capsule |
| 01/28/2010 | US20100021533 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| 01/28/2010 | US20100021522 Sustained delivery of exenatide and other peptides |
| 01/28/2010 | US20100021520 Biomaterial implants |
| 01/28/2010 | US20100021518 Foam carrier for bone grafting |
| 01/28/2010 | US20100021517 Non-woven fiber fabric |
| 01/28/2010 | US20100021510 Neuronal exocytosis inhibiting peptides |
| 01/28/2010 | US20100021505 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients |
| 01/28/2010 | US20100021503 Immunogenic composition |
| 01/28/2010 | US20100021500 Processes for treating subjects carrying viral infectious agent |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021480 Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021465 Boris isoforms and methods of detecting and treating disease |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021456 Drug for inhibiting,preventing or treatment of rheumatoid arthritis |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | US20100021450 Lys K Endolysin Is Synergistic with Lysostaphin Against MRSA |
| 01/28/2010 | US20100021449 ANGIOGENIN COMPLEXES (ANGex) AND USES THEREOF |
| 01/28/2010 | US20100021448 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 01/28/2010 | US20100021447 Medicament for Treating Problems Relating to Fertility and Pregnancy, and Autoimmune Diseases, and for Inducing an Immunological Tolerance in Transplant Patients, and Method for Producing Said Medicament |
| 01/28/2010 | US20100021446 Use of Polypeptides Against Diseases Caused by Protozoans |
| 01/28/2010 | US20100021442 Method for promoting immunotherapy using an agent for elevating dendritic cell precursor level in blood |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021440 Use of tropoelastin for repair or restoration of tissue |
| 01/28/2010 | US20100021439 Methods and compositions for treating intervertebral disc degeneration |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | US20100021429 Cladribine regimen for treating multiple sclerosis |
| 01/28/2010 | US20100021428 Use Of Gelsolin To Treat Multiple Sclerosis And To Diagnose Neurologic Disease (Stossel) |
| 01/28/2010 | US20100021427 Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV |
| 01/28/2010 | US20100021426 Methods for making and compositions comprising fermentation products of cordyceps sinensis |
| 01/28/2010 | US20100021425 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 01/28/2010 | US20100021424 Method For Identifying Whether A Patient Will Be Responder or Not to Immunotherapy |
| 01/28/2010 | US20100021423 Heterocyclic antiviral compounds |
| 01/28/2010 | US20100021422 Methods and compositions for delivery of exogenous factors to nervous system sites |
| 01/28/2010 | US20100021421 Fusion proteins and methods for modulation of immune response |
| 01/28/2010 | US20100021420 Combinations of pyrazole derivatives for the inhibition of cdks and gsk's |
| 01/28/2010 | US20100021419 Stable Pharmaceutical Composition Comprising Granulocyte-Colony Stimulating Factor |
| 01/28/2010 | US20100021416 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | US20100021401 Method for treating skin |
| 01/28/2010 | US20100021380 Dieghylenetriaminepentaacetic acid (dtpa)-modified ferrofluid, preparation method of the same and uses of the same in preparation of peptide ferrofluid |
| 01/28/2010 | US20100017972 Biodegradable polymeric derivatives |
| 01/28/2010 | CA2737146A1 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | CA2737144A1 Methods for treating viral disorders |
| 01/28/2010 | CA2736842A1 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | CA2736062A1 Triple acting antimicrobials that are refractory to resistance development |
| 01/28/2010 | CA2732737A1 Cancer peptide therapeutics |
| 01/28/2010 | CA2732016A1 Tissue kallikrein for the treatment of parkinson's disease |
| 01/28/2010 | CA2731880A1 Compositions for the treatment of pain and/or inflammation |
| 01/28/2010 | CA2731827A1 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 01/28/2010 | CA2731547A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | CA2731463A1 Compositions and methods for increasing serum antioxidant concentrations |
| 01/28/2010 | CA2731459A1 Methods for diagnosis and prognosis of skin cancer |
| 01/28/2010 | CA2731388A1 Tnfsf single chain molecules |
| 01/28/2010 | CA2731247A1 Csf biomarkers for the prediction of cognitive decline in alzheimer's disease patients |
| 01/28/2010 | CA2731236A1 Transdermal system for extended delivery of incretins and incretin mimetic peptides |
| 01/28/2010 | CA2731177A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 01/28/2010 | CA2730804A1 Amyloid .beta. peptide analogues, oligomers thereof, processes for preparing and compositions comprising said analogues or oligomers, and their uses |
| 01/28/2010 | CA2730132A1 Novel angiopoietin derived peptides |
| 01/28/2010 | CA2729296A1 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 01/27/2010 | EP2147978A2 N-Terminally truncated HER-2/NEU protein as a cancer prognostic indicator |
| 01/27/2010 | EP2147930A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147929A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147928A2 Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147927A2 Use of 131i-tm-601 for the diagnosis and treatment of gliomas |
| 01/27/2010 | EP2147925A1 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/27/2010 | EP2147681A1 Compositions and methods for treating lysosomal storage disease |
| 01/27/2010 | EP2147680A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP2147672A1 Cytotoxic t cell activator comprising ep4 agonist |